MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29516-29528

  Selcuklu, S Duygu ^a   Donoghue, Mark T A ^a   Rehmet, Kristina ^a   De Gomes, Matheus Souza ^a   Fort, Antoine ^a   Kovvuru, Prasad ^a   Muniyappa, Mohan K ^a   Kerin, Michael J ^a   Enright, Anton J ^b   Spillane, Charles ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-PROLIFERATIVE; ANTIAPOPTOTIC ACTIVITIES; APOPTOTIC ACTIVITY; BREAST CANCER CELLS; BREAST TUMOR; CANCER CELLS; CELL LINES; CELL VIABILITY; ENDOGENOUS EXPRESSION; EXPRESSION LEVELS; EXPRESSION PROFILE; MCF-7 CELLS; OVER-EXPRESSION; TARGET GENES; TRANSCRIPTOME PROFILING; TRANSCRIPTOMES; TUMOR SUPPRESSORS;

CELL CULTURE; CELL PROLIFERATION; GENES; TUMORS;

CELLS;

MICRORNA 9; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; AP3B1 GENE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CCNG1 GENE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LARP1 GENE; MTHFD1L GENE; MTHFD2 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN TARGETING; SRPK1 GENE; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM PROTEINS; RNA, NEOPLASM; TRANSCRIPTOME;

EID: 84865488949     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.335943     Document Type: Article

References (76)

1. Schickel, R., Boyerinas, B., Park, S. M., and Peter, M. E. (2008) MicroRNAs. Key players in the immune system, differentiation, tumorigenesis, and cell death. Oncogene 27, 5959-5974
2. Zhang, B., Pan, X., Cobb, G. P., and Anderson, T. A. (2007) MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12
3. He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., and Hammond, S. M. (2005) A microRNA polycistron as a potential human oncogene. Nature 435, 828-833
4. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., and Golub, T. R. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838
5. Ma, L., Teruya-Feldstein, J., and Weinberg, R. A. (2007) Tumorinvasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688
6. Selcuklu, S. D., Donoghue, M. T., and Spillane, C. (2009) miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 37, 918-925
7. Jiang, S., Zhang, H. W., Lu, M. H., He, X. H., Li, Y., Gu, H., Liu, M. F., and Wang, E. D. (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 70, 3119-3127
8. Yu, Z., Willmarth, N. E., Zhou, J., Katiyar, S., Wang, M., Liu, Y., McCue, P. A., Quong, A. A., Lisanti, M. P., and Pestell, R. G. (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc. Natl. Acad. Sci. U. S. A. 107, 8231-8236
9. Welch, C., Chen, Y., and Stallings, R. L. (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022
10. Krichevsky, A. M., Sonntag, K. C., Isacson, O., and Kosik, K. S. (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24, 857-864
11. Laios, A., O'Toole, S., Flavin, R., Martin, C., Kelly, L., Ring, M., Finn, S. P., Barrett, C., Loda, M., Gleeson, N., D'Arcy, T., McGuinness, E., Sheils, O., Sheppard, B., and O' Leary, J. (2008) Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer 7, 35
12. Khew-Goodall, Y., and Goodall, G. J. (2010) Myc-modulated miR-9 makes more metastases. Nat. Cell Biol. 12, 209-211
13. Nass, D., Rosenwald, S., Meiri, E., Gilad, S., Tabibian-Keissar, H., Schlosberg, A., Kuker, H., Sion-Vardy, N., Tobar, A., Kharenko, O., Sitbon, E., Lithwick Yanai, G., Elyakim, E., Cholakh, H., Gibori, H., Spector, Y., Bentwich, Z., Barshack, I., and Rosenfeld, N. (2009) MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 19, 375-383
14. Shah, T., Wildes, F., Penet, M. F., Winnard, P. T., Jr., Glunde, K., Artemov, D., Ackerstaff, E., Gimi, B., Kakkad, S., Raman, V., and Bhujwalla, Z. M. (2010) Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. NMR Biomed. 23, 633-642
15. Tan, H. X., Wang, Q., Chen, L. Z., Huang, X. H., Chen, J. S., Fu, X. H., Cao, L. Q., Chen, X. L., Li, W., and Zhang, L. J. (2010) MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol 27, 654-660
16. Luo, H., Zhang, H., Zhang, Z., Zhang, X., Ning, B., Guo, J., Nie, N., Liu, B., and Wu, X. (2009) Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res. 28, 82
17. Wan, H. Y., Guo, L. M., Liu, T., Liu, M., Li, X., and Tang, H. (2010) Regulation of the transcription factor NF-κB1 by microRNA-9 in human gastric adenocarcinoma. Mol. Cancer 9, 16
18. Guo, L. M., Pu, Y., Han, Z., Liu, T., Li, Y. X., Liu, M., Li, X., and Tang, H. (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1. FEBS J. 276, 5537-5546
19. Guled, M., Lahti, L., Lindholm, P. M., Salmenkivi, K., Bagwan, I., Nicholson, A. G., and Knuutila, S. (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma. A miRNA microarray analysis. Genes Chromosomes Cancer 48, 615-623
20. Lehmann, U., Hasemeier, B., Christgen, M., Müller, M., Römermann, D., Länger, F., and Kreipe, H. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol 214, 17-24
21. Hsu, P. Y., Deatherage, D. E., Rodriguez, B. A., Liyanarachchi, S., Weng, Y. I., Zuo, T., Liu, J., Cheng, A. S., and Huang, T. H. (2009) Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69, 5936-5945
22. Bandres, E., Agirre, X., Bitarte, N., Ramirez, N., Zarate, R., Roman-Gomez, J., Prosper, F., and Garcia-Foncillas, J. (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 125, 2737-2743
23. Hildebrandt, M. A., Gu, J., Lin, J., Ye, Y., Tan, W., Tamboli, P., Wood, C. G., and Wu, X. (2010) Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29, 5724-5728
24. Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., Gallagher, W. M., Eccles, S. A., Croce, C. M., and Esteller, M. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U. S. A. 105, 13556-13561
25. Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., and Davidson, B. L. (2008) The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is down-regulated in Huntington disease. J. Neurosci. 28, 14341-14346
26. Zhao, C., Sun, G., Li, S., and Shi, Y. (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 16, 365-371
27. Chao, T. F., Zhang, Y., Yan, X. Q., Yin, B., Gong, Y. H., Yuan, J. G., Qiang, B. Q., and Peng, X. Z. (2008) MiR-9 regulates the expression of CBX7 in human glioma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 30, 268-274
28. Rotkrua, P., Akiyama, Y., Hashimoto, Y., Otsubo, T., and Yuasa, Y. (2011) MiR-9 down-regulates CDX2 expression in gastric cancer cells. Int. J. Cancer 129, 2611-2620
29. Marín-Vidalled, M. J., Bolívar, A., Zubiaga, A., and López-Hoyos, M. (2010) The combined effect of BCL-2 overexpression and E2F2 deficiency induces an autoimmune syndrome in non-susceptible mouse strain C57BL/6. Autoimmunity 43, 111-120
30. Godbey, W. T., and Atala, A. (2003) Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery. Gene therapy 10, 1519-1527
31. Ngoka, L. C. (2008) Sample prep for proteomics of breast cancer. Proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers. Proteome Sci. 6, 30
32. Prasannan, P., and Appling, D. R. (2009) Human mitochondrial C1-tetrahydrofolate synthase. Submitochondrial localization of the full-length enzyme and characterization of a short isoform. Arch. Biochem. Biophys. 481, 86-93
33. Xue, L. Y., Chiu, S. M., and Oleinick, N. L. (2003) Staurosporine-induced death of MCF-7 human breast cancer cells. A distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions. Exp. Cell Res. 283, 135-145
34. Kurokawa, H., Nishio, K., Fukumoto, H., Tomonari, A., Suzuki, T., and Saijo, N. (1999) Alteration of caspase-3 (CPP32/Yama/apopain) in wildtype MCF-7, breast cancer cells. Oncol. Rep. 6, 33-37
35. Mc Gee, M. M., Hyland, E., Campiani, G., Ramunno, A., Nacci, V., and Zisterer, D. M. (2002) Caspase-3 is not essential forDNAfragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6. FEBS Lett. 515, 66-70
36. Kottke, T. J., Blajeski, A. L., Meng, X. W., Svingen, P. A., Ruchaud, S., Mesner, P. W., Jr., Boerner, S. A., Samejima, K., Henriquez, N. V., Chilcote, T. J., Lord, J., Salmon, M., Earnshaw, W. C., and Kaufmann, S. H. (2002) Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. J. Biol. Chem. 277, 804-815
37. van Dongen, S., Abreu-Goodger, C., and Enright, A. J. (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat. Methods 5, 1023-1025
38. Bartonicek, N., and Enright, A. J. (2010) SylArray. a web server for automated detection of miRNA effects from expression data. Bioinformatics 26, 2900-2901
39. Sun, R., Fu, X., Li, Y., Xie, Y., and Mao, Y. (2009) Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumors. BMC Genomics 10, 93
40. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., and Johnson, J. M. (2005) Microarray analysis shows that some microRNAs down-regulate large numbers of target mRNAs. Nature 433, 769-773
41. Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C. G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., Croce, C. M., Bolondi, L., and Negrini, M. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099
42. Xu, X., Qiao, M., Zhang, Y., Jiang, Y., Wei, P., Yao, J., Gu, B., Wang, Y., Lu, J., Wang, Z., Tang, Z., Sun, Y., Wu, W., and Shi, Q. (2010) Quantitative proteomics study of breast cancer cell lines isolated from a single patient. Discovery of TIMM17A as a marker for breast cancer. Proteomics 10, 1374-1390
43. Burrows, C., Abd Latip, N., Lam, S. J., Carpenter, L., Sawicka, K., Tzolovsky, G., Gabra, H., Bushell, M., Glover, D. M., Willis, A. E., and Blagden, S. P. (2010) The RNA binding protein Larp1 regulates cell division, apoptosis, and cell migration. Nucleic Acids Res. 38, 5542-5553
44. Hayes, G. M., Carrigan, P. E., and Miller, L. J. (2007) Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res. 67, 2072-2080
45. Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132
46. Zhao, H., Langerød, A., Ji, Y., Nowels, K. W., Nesland, J. M., Tibshirani, R., Bukholm, I. K., Kåresen, R., Botstein, D., Børresen-Dale, A. L., and Jeffrey, S. S. (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523-2536
47. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A. M. (2004) ONCOMINE. a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6
48. Zhu, L., Chen, H., Zhou, D., Li, D., Bai, R., Zheng, S., and Ge, W. (2012) MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med. Oncol. 29, 1037-1043
49. Tränkenschuh, W., Puls, F., Christgen, M., Albat, C., Heim, A., Poczkaj, J., Fleming, P., Kreipe, H., and Lehmann, U. (2010) Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS One 5, e13688
50. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70
51. Jänicke, R. U., Ng, P., Sprengart, M. L., and Porter, A. G. (1998) Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273, 15540-15545
52. Talanian, R. V., Quinlan, C., Trautz, S., Hackett, M. C., Mankovich, J. A., Banach, D., Ghayur, T., Brady, K. D., and Wong, W. W. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682
53. Spruce, B. A., Campbell, L. A., McTavish, N., Cooper, M. A., Appleyard, M. V., O'Neill, M., Howie, J., Samson, J., Watt, S., Murray, K., McLean, D., Leslie, N. R., Safrany, S. T., Ferguson, M. J., Peters, J. A., Prescott, A. R., Box, G., Hayes, A., Nutley, B., Raynaud, F., Downes, C. P., Lambert, J. J., Thompson, A. M., and Eccles, S. (2004) Small molecule antagonists of the δ1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res. 64, 4875-4886
54. Twiddy, D., Cohen, G. M., Macfarlane, M., and Cain, K. (2006) Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex. J. Biol. Chem. 281, 3876-3888
55. Dalmay, T., and Edwards, D. R. (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170-6175
56. Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., and Mo, Y. Y. (2008) MicroRNA- 21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350-359
57. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation, and metastasis in colorectal cancer. Oncogene 27, 2128-2136
58. Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., and Jacks, T. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677
59. Fang, X. J., Jiang, H., Zhao, X. P., and Jiang, W. M. (2011) The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7. BMC Cancer 11, 290
60. Fox, B. P., and Kandpal, R. P. (2004) Invasiveness of breast carcinoma cells and transcript profile. Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem. Biophys. Res. Commun. 318, 882-892
61. Fornari, F., Gramantieri, L., Giovannini, C., Veronese, A., Ferracin, M., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Tavolari, S., Chieco, P., Negrini, M., and Bolondi, L. (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69, 5761-5767
62. Perez, R., Wu, N., Klipfel, A. A., and Beart, R. W., Jr. (2003) A better cell cycle target for gene therapy of colorectal cancer. cyclin G. J. Gastrointest Surg. 7, 884-889
63. Gordon, E. M., Liu, P. X., Chen, Z. H., Liu, L., Whitley, M. D., Gee, C., Groshen, S., Hinton, D. R., Beart, R. W., and Hall, F. L. (2000) Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrixtargeted retroviral vectors bearing a cytocidal cyclin G1 construct. Cancer Res. 60, 3343-3347
64. Liang, J., Bian, M. L., Chen, Q. Y., Liu, X., Ou, H., Li, M., and Liu, J. (2006) Relationship between cyclin G1 and human papilloma virus infection in cervical intraepithelial neoplasia and cervical carcinoma. Chin. Med. Sci. J. 21, 81-85
65. Krishnakumar, S., Mohan, A., Kandalam, M., Ramkumar, H. L., Venkatesan, N., and Das, R. R. (2008) SRPK1. a cisplatin sensitive protein expressed in retinoblastoma. Pediatr. Blood Cancer 50, 402-406
66. Schenk, P. W., Boersma, A. W., Brandsma, J. A., den Dulk, H., Burger, H., Stoter, G., Brouwer, J., and Nooter, K. (2001) SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res. 61, 6982-6986
67. Plasencia, C., Martínez-Balibrea, E., Martinez-Cardús, A., Quinn, D. I., Abad, A., and Neamati, N. (2006) Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. Int. J. Oncol 29, 225-235
68. Thorsen, K., Mansilla, F., Schepeler, T., Oster, B., Rasmussen, M. H., Dyrskjot, L., Karni, R., Akerman, M., Krainer, A. R., Laurberg, S., Andersen, C. L., and Orntoft, T. F. (2011) Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Mol. Cell Proteomics 10, M110.002998
69. Sanidas, I., Kotoula, V., Ritou, E., Daans, J., Lenz, C., Mairhofer, M., Daniilidou, M., Kolbus, A., Kruft, V., Ponsaerts, P., and Nikolakaki, E. (2010) The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells. Biochim. Biophys. Acta 1803, 1319-1331
70. Petrenko, A. A., Pavlova, L. S., Karseladze, A. I., Kisseljov, F. L., and Kisseljova, N. P. (2006) Down-regulation of genes encoding for subunits of adaptor complex-3 in cervical carcinomas. Biochemistry 71, 1153-1160
71. Mantripragada, K. K., Díaz de Ståhl, T., Patridge, C., Menzel, U., Andersson, R., Chuzhanova, N., Kluwe, L., Guha, A., Mautner, V., Dumanski, J. P., and Upadhyaya, M. (2009) Genome-wide high resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes Chromosomes Cancer 48, 897-907
72. Parle-McDermott, A., Pangilinan, F., O'Brien, K. K., Mills, J. L., Magee, A. M., Troendle, J., Sutton, M., Scott, J. M., Kirke, P. N., Molloy, A. M., and Brody, L. C. (2009) A common variant in MTHFD1L is associated with neural tube defects and mRNA splicing efficiency. Hum. Mutat 30, 1650-1656
73. Christensen, K. E., and Mackenzie, R. E. (2008) Mitochondrial methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetases. Vitam. Horm. 79, 393-410
74. Andrew, A. S., Gui, J., Sanderson, A. C., Mason, R. A., Morlock, E. V., Schned, A. R., Kelsey, K. T., Marsit, C. J., Moore, J. H., and Karagas, M. R. (2009) Bladder cancer SNP panel predicts susceptibility and survival. Hum. Genet. 125, 527-539
75. Sertel, S., Eichhorn, T., Sieber, S., Sauer, A., Weiss, J., Plinkert, P. K., and Efferth, T. (2010) Factors determining sensitivity or resistance of tumor cell lines toward artesunate. Chem. Biol. Interact 185, 42-52
76. Bigelow, R. L., Williams, B. J., Carroll, J. L., Daves, L. K., and Cardelli, J. A. (2009) TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Breast Cancer Res. Treat. 117, 31-44